Pfizer Secures USFDA Priority Review to Expand Talzenna-Xtandi Use in Prostate Cancer Written By sheeba farhat23 July 2026 10:28 PM ISTBengaluru: Pfizer said on Wednesday the U.S. Food and Drug Administration had granted priority review to its application seeking expanded approval for...
Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects: Study Written By Dr. Kamal Kant Kohli1 July 2026 9:00 PM ISTTwo larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of radiotherapy, according...
Lifestyle factors may influence prostate cancer risk in Indian men, finds study Written By Dr. Kamal Kant Kohli22 Jun 2026 9:00 PM ISTA new research paper was published in Volume 13 of Oncoscience on April 28, 2026, titled "Modifiable risk factors of prostate cancer: Insights from a...
Add on Apalutamide to ADT Improves Outcomes after Prostate Cancer Surgery: NEJM Written By Jacinthlyn Sylvia9 Jun 2026 9:15 PM ISTA new study published in The New England Journal of Medicine showed that when compared to androgen deprivation therapy (ADT) plus placebo,...
Redefining Grade Group 1 Prostate Disease May Reduce Prostate Cancer Deaths: JAMA Written By Medha Baranwal5 Jun 2026 10:00 PM ISTUSA: Researchers have found in a new study that removing the "cancer" label from Grade Group 1 (GG1) prostate disease and redefining it as a...
New Biomarker Predicts Immunotherapy Benefit in Advanced Prostate Cancer, finds study Written By Dr. Kamal Kant Kohli28 May 2026 9:00 PM ISTResearchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new gene expression signature...
Tomato-soy juice lowers inflammation in adults with obesity, suggests study Written By Dr. Kamal Kant Kohli27 May 2026 7:45 AM ISTDrinking tomato-soy juice loaded with compounds shown in animal studies to promote health lowered pro-inflammatory proteins in healthy adults with...
Urine test better than MRI for monitoring low-risk prostate cancer in new study Written By Dr. Kamal Kant Kohli11 May 2026 8:00 AM ISTA new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to...
New study shows faster recovery with minimally invasive prostate cancer treatment: Study Written By Dr. Kamal Kant Kohli20 April 2026 8:30 PM ISTA new randomized clinical trial found that men with localized, intermediate-risk prostate cancer recovered faster and experienced less short-term...
No False Advertising Found: US Court Rejects Bayer Plea to Block Johnson and Johnson's Erleada Ads Written By sheeba farhat18 April 2026 7:22 PM ISTNew York: A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its...
Low testosterone levels tied to increased risk of prostate cancer progression during surveillance: Study Written By Dr. Kamal Kant Kohli2 April 2026 8:45 PM ISTA new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels...
Do prostate cancer drugs interact with certain anticoagulants to increase bleeding and clotting risks? Written By Dr. Kamal Kant Kohli27 March 2026 9:30 AM ISTIn a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators...
